Quarterly Sales Jump And Buyback Completion Could Be A Game Changer For Cohu (COHU)
- Cohu, Inc. reported past second-quarter 2026 results showing sales rising to US$149 million from US$107.68 million a year earlier, with net loss shrinking to US$0.159 million, and issued third-quarter 2026 sales guidance of US$170 million plus or minus US$7 million.
- The company has now completed a share repurchase of 4,022,737 shares, or 8.43% of its stock, for US$117.17 million under its October 2021 buyback program, while simultaneously showing improved year-over-year profitability metrics.
- We will examine how Cohu’s improved quarterly loss reduction and new sales guidance shape its investment narrative for investors.
Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
What Is Cohu's Investment Narrative?
For Cohu, the core investment idea is whether you believe its test platforms can keep winning sockets in AI, HPC and power devices while the company works its way back to consistent profitability. The latest quarter helps that story: Q2 2026 sales stepped up to US$149 million with the net loss almost eliminated, and Q3 guidance of about US$170 million in sales points to near term operating leverage as volumes improve. That said, the business is still loss making and the stock has already run very hard over the past year, which keeps execution risk front and center if the Q3 ramp or AI related orders slow. The completed 8.43% buyback adds a supportive capital allocation angle, but the fresh authorized share increase could cut both ways depending on how it is eventually used.
However, investors should not overlook how quickly sentiment could reverse if growth stumbles. Cohu's shares are on the way up, but they could be overextended by 46%. Uncover the fair value now.Exploring Other Perspectives
Explore 3 other fair value estimates on Cohu - why the stock might be worth 31% less than the current price!
Reach Your Own Conclusion
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Cohu research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Cohu research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cohu's overall financial health at a glance.
Curious About Other Options?
Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:
- AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com